SUMO Modification of Histone Demethylase KDM4A in Kaposi’s Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Virology"
DOI: 10.1128/jvi.00755-22
Abstract: PEL is an aggressive and untreatable B-cell lymphoma caused by KSHV infection. Therefore, new therapeutic approaches for PEL need to be investigated. ABSTRACT Primary effusion lymphoma (PEL) is a fatal B-cell lymphoma caused by Kaposi’s… read more here.
Keywords: cell; lymphoma; kdm4a; pel cells ... See more keywords
Nigericin Induces Apoptosis in Primary Effusion Lymphoma Cells by Mitochondrial Membrane Hyperpolarization and β-Catenin Destabilization
Sign Up to like & getrecommendations! Published in 2023 at "AntiCancer Research"
DOI: 10.21873/anticanres.16413
Abstract: Background/Aim: Primary effusion lymphoma (PEL) is classified as a rare non-Hodgkin’s B-cell lymphoma that is caused by Kaposi’s sarcoma-associated herpesvirus (KSHV); PEL cells are latently infected with KSHV. PEL is frequently resistant to conventional chemotherapies.… read more here.
Keywords: lymphoma; pel cells; pel; mitochondrial membrane ... See more keywords
A pyridinium-type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β-catenin
Sign Up to like & getrecommendations! Published in 2022 at "Oncology Reports"
DOI: 10.3892/or.2022.8257
Abstract: Primary effusion lymphoma (PEL) is defined as a rare subtype of non-Hodgkin's B cell lymphoma, which is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) in immunosuppressed patients. PEL is an aggressive type of lymphoma and is… read more here.
Keywords: catenin; type fullerene; pyridinium type; pel cells ... See more keywords